Abstract:Objective:To analyze the clinicopathological features, prognosis and possible causes of omitting diagnosis in cutaneous malignant melanoma cases with false-negative sentinel lymph nodes(SLN), and try to find ways to improve the positive detection rate of SLN.Methods:Thirty nine cases of malignant melanoma with false-negative SLN biopsy in Peking University Cancer Hospital and Beijing Southern Suburb Cancer Hospital between 2009 to 2018 were collected, and their clinicopathological features and prognosis were analyzed. The possible reasons for missed detection were studied by reviewing the original HE sections, thinly cutting tissue and immunohistochemical staining.Results:There were 39 false-negative cases, and the false-negative rate was 26%. Features of primary lesions showed that the most common site was lower extremities (64%), the median Breslow thickness was 4.0 mm with 71% of them in Clark level Ⅳ, ulcer was seen in 59% of these cases, and a mitotic rate more than 2 per square millimeters was found in 60% of them. The proportion of cases with Breslow thickness more than 4.0 mm was significantly higher in patients who underwent skin transitional metastasis or recurrence prior to regional lymph node metastasis than in other patients. After a 16.7~137.2 months' follow-up, the 5-year melanoma specific survival rate was 67.6%, and the median survival time was 70.2 months. Multivariate analysis showed that the prognosis of the group aged <60 years was significantly worse than that of the group aged ≥60 years. After thorough pathological reviews, 10 cases were finally detected positive, with a positive detection rate of 25.6%, and the false negative rate of SLN after review was 19%. Four cases were detected with median power review of the original HE section, all of which were found in the marginal sinus with a diameter ≤0.2 mm and mainly a nevus like morphology. Five cases were positive after thinly cutting tissue, and 4 cases of them showed a diameter between 1.8 to 4.5 mm, among which 2 cases were found in the area where the original HE section was not completely sliced. Three cases were ambiguous after morphological review and SOX-10 staining was used, and one case with a micro metastasis was detected.Conclusions:Positive SLNs detected after review were mostly micro metastases in the marginal sinus. Full and intact exposure of the submembranous tissue of SLN, careful examination of the slides and immunohistochemical staining are helpful to improve the positive detection rate of SLN. In terms of prognosis, multivariate analysis showed that age <60 years old was a poor prognostic factor for SLN false negative melanoma.

Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data.

Role of Number of Sentinel Nodes in Predicting Non-Sentinel Node Metastasis in Breast Cancer

Clinical Study of Sentinel Lymph Node Biopsy in Colon Cancer

The Prognostic Significance of Non‐sentinel Lymph Node Metastasis in Cutaneous and Acral Melanoma Patients—a Multicenter Retrospective Study

Prognostic Value of the Number of Biopsied Sentinel Lymph Nodes for Chinese Patients with Melanoma: A Single-Center Retrospective Study

Risk factors and prognosis of sentinel lymph node metastasis in breast-conserving breast cancer: A retrospective study based on the SEER database

False-negative sentinel lymph node biopsy for melanoma: a single-surgeon experience

136P Assessment of Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection on Long-Term Survival in Breast Cancer Patients with Pathologically Negative Lymph Node

Sentinel Lymph Node Biopsy in Nonmelanoma Skin Cancer Patients

The prognostic significance of further axillary dissection for sentinel lymph node micrometastases in female breast cancer: A competing risk analysis using the SEER database

Investigation of Prognostic Factors for Non-Sentinel Lymph Node Metastasis in Patients Undergoing Sentinel Lymph Node Biopsy for Cutaneous Malignant Melanoma: Experience from a Reference Center in Turkey

The benefit of sentinel lymph node biopsy in elderly patients with melanoma: A retrospective analysis of SEER Medicare data (2010-2018)

Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients

Analysis of the clinicopathological features, prognosis and causes of omitting diagnosis in melanoma cases with false-negative sentinel lymph nodes

Survival Outcomes Following Lymph Node Biopsy in Thin Melanoma—A Propensity-Matched Analysis

Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 years

The Role of Sentinel Node Biopsy in the Era of Adjuvant Therapy for Melanoma

A role for pelvic sentinel lymph nodes in lower extremity melanoma?

Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma—A Retrospective Single-Institute Study

Between Pathological Prostate Cancer Lymph Nodes and Sentinel Nodes

Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy